
A new cost analysis finds that matching relapsed lymphoma treatment to a personalized drug-response test was associated with longer disease control and a lower estimated daily treatment cost in dogs.
Algorithm: Administering ACE inhibitors and ARBs to treat proteinuria in dogs with glomerular disease (PDF)






